FREIBURG, Germany–(BUSINESS WIRE)–Accenture (NYSE: ACN) has agreed to acquire consus.health, a leading German healthcare management consultancy. consus.health offers services ranging from medical strategy and patient management to procurement and logistics, infrastructure management and construction planning services. By adding consus.health’s strategy and industry consulting skills to its capabilities in digital transformation and managed services, Accenture will enhance its ability to help healthcare providers and hospitals across Germany, Austria and Switzerland improve their quality of care.
Founded in 2012, consus.health has a strong presence in the German market serving more than 600 healthcare providers and hospitals. With a deep strategy and industry consulting know-how and a strong industry network in the healthcare market, consus.health has built a track record in improving the financial and operational performance of its clients. Their services include streamlining operations and enhancing both strategy and financial management to help clients manage costs and protect revenues. They also advise on improving the infrastructure, logistics and energy efficiency of hospitals as well as on optimizing their construction. Part of their portfolio is the consus healthcare akademie that offers more than 90 training courses for all levels of healthcare professionals. Headquartered in Freiburg im Breisgau, consus.health’s team of 140 experts will join Accenture’s Health Strategy & Consulting practice in Germany.
“In the healthcare industry, organizations are under pressure to improve access, experience and outcomes, while reducing costs,” said Christina Raab, market unit lead for Accenture in Austria, Switzerland and Germany. “consus.health’s industry expertise will enhance our capabilities that help healthcare organizations with their digital transformation journeys and drive efficiency at the same time.”
“The acquisition of consus.health is a significant milestone in our strategy to serve clients end-to-end in an expanding healthcare market,” said Katharina Michaelis, Accenture’s social services and health portfolio lead for Germany. “consus.health’s expertise in revenue and cost management, process optimization, and hospital management will complement our existing offerings and enable us to provide our clients with even more comprehensive solutions.”
“By joining Accenture, we will continue our mission of structurally and economically empowering healthcare organizations to care for their patients,” said Dr Djordje Nikolic, founder and CEO of consus.health. “I am convinced that with Accenture’s digital expertise and consus.health’s healthcare know-how, we will help make a difference in healthcare and offer exciting new opportunities to our employees.” Nikolic will lead Accenture’s Health Strategy & Consulting practice in Austria, Switzerland and Germany and will be responsible to build-up and grow the health provider business.
The acquisition of consus.health is the latest in a series of strategic investments that Accenture has made to position itself as a leading provider of consulting, digital transformation and managed services in the healthcare sector including Intellera Consulting, ConcentricLife and Nautilus Consulting.
Terms of the transaction were not disclosed. Completion of the acquisition is subject to customary closing conditions.
Forward-Looking Statements
Except for the historical information and discussions contained herein, statements in this news release may constitute forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Words such as “may,” “will,” “should,” “likely,” “anticipates,” “aspires,” “expects,” “intends,” “plans,” “projects,” “believes,” “estimates,” “positioned,” “outlook,” “goal,” “target” and similar expressions are used to identify these forward-looking statements. These statements are not guarantees of future performance nor promises that goals or targets will be met, and involve a number of risks, uncertainties and other factors that are difficult to predict and could cause actual results to differ materially from those expressed or implied. These risks include, without limitation, risks that: Accenture and consus.health will not be able to close the transaction in the time period anticipated, or at all, which is dependent on the parties’ ability to satisfy certain closing conditions; the transaction might not achieve the anticipated benefits for Accenture; Accenture’s results of operations have been, and may in the future be, adversely affected by volatile, negative or uncertain economic and political conditions and the effects of these conditions on the company’s clients’ businesses and levels of business activity; Accenture’s business depends on generating and maintaining client demand for the company’s services and solutions including through the adaptation and expansion of its services and solutions in response to ongoing changes in technology and offerings, and a significant reduction in such demand or an inability to respond to the evolving technological environment could materially affect the company’s results of operations; if Accenture is unable to match people and their skills with client demand around the world and attract and retain professionals with strong leadership skills, the company’s business, the utilization rate of the company’s professionals and the company’s results of operations may be materially adversely affected; Accenture faces legal, reputational and financial risks from any failure to protect client and/or company data from security incidents or cyberattacks; the markets in which Accenture operates are highly competitive, and Accenture might not be able to compete effectively; Accenture’s ability to attract and retain business and employees may depend on its reputation in the marketplace; if Accenture does not successfully manage and develop its relationships with key ecosystem partners or fails to anticipate and establish new alliances in new technologies, the company’s results of operations could be adversely affected; Accenture’s profitability could materially suffer if the company is unable to obtain favourable pricing for its services and solutions, if the company is unable to remain competitive, if its cost-management strategies are unsuccessful or if it experiences delivery inefficiencies or fail to satisfy certain agreed-upon targets or specific service levels; changes in Accenture’s level of taxes, as well as audits, investigations and tax proceedings, or changes in tax laws or in their interpretation or enforcement, could have a material adverse effect on the company’s effective tax rate, results of operations, cash flows and financial condition; Accenture’s results of operations could be materially adversely affected by fluctuations in foreign currency exchange rates; changes to accounting standards or in the estimates and assumptions Accenture makes in connection with the preparation of its consolidated financial statements could adversely affect its financial results; as a result of Accenture’s geographically diverse operations and strategy to continue to grow in key markets around the world, the company is more susceptible to certain risks; if Accenture is unable to manage the organizational challenges associated with its size, the company might be unable to achieve its business objectives; Accenture might not be successful at acquiring, investing in or integrating businesses, entering into joint ventures or divesting businesses; Accenture’s business could be materially adversely affected if the company incurs legal liability; Accenture’s global operations expose the company to numerous and sometimes conflicting legal and regulatory requirements; Accenture’s work with government clients exposes the company to additional risks inherent in the government contracting environment; if Accenture is unable to protect or enforce its intellectual property rights or if Accenture’s services or solutions infringe upon the intellectual property rights of others or the company loses its ability to utilize the intellectual property of others, its business could be adversely affected; Accenture may be subject to criticism and negative publicity related to its incorporation in Ireland; as well as the risks, uncertainties and other factors discussed under the “Risk Factors” heading in Accenture plc’s most recent Annual Report on Form 10-K and other documents filed with or furnished to the Securities and Exchange Commission. Statements in this news release speak only as of the date they were made, and Accenture undertakes no duty to update any forward-looking statements made in this news release or to conform such statements to actual results or changes in Accenture’s expectations.
About Accenture
Accenture is a leading global professional services company that helps the world’s leading businesses, governments and other organizations build their digital core, optimize their operations, accelerate revenue growth and enhance citizen services—creating tangible value at speed and scale. We are a talent- and innovation-led company with approximately 750,000 people serving clients in more than 120 countries. Technology is at the core of change today, and we are one of the world’s leaders in helping drive that change, with strong ecosystem relationships. We combine our strength in technology and leadership in cloud, data and AI with unmatched industry experience, functional expertise and global delivery capability. We are uniquely able to deliver tangible outcomes because of our broad range of services, solutions and assets across Strategy & Consulting, Technology, Operations, Industry X and Song. These capabilities, together with our culture of shared success and commitment to creating 360° value, enable us to help our clients reinvent and build trusted, lasting relationships. We measure our success by the 360° value we create for our clients, each other, our shareholders, partners and communities. Visit us at www.accenture.com.
Copyright ©2024 Accenture. All rights reserved. Accenture and its logo are registered trademarks of Accenture.
Contacts
Thomas Wittek
Accenture
+49 151 52507486
thomas.wittek@accenture.com